TriApex Laboratories Co., Ltd. (TriApex), founded in 2008, is an innovative CRO dedicated to providing disease-oriented integrated solutions to enable the R&D for global pharmaceutical enterprises and research institutions.
TriApex takes scientific research, enabling new drug R&D, and improving quality of patients’ life as its own mission. Relying on the top technical service team in the industry, TriApex builds and improves group management, focuses on the pathogenesis and models of diseases, nonclinical research, and clinical and translational research by means of highly scientific and professional operation strategies.
TriApex, taking advantage of its excellent service quality and abundant industry experience, powers innovation of technologies, leads industry innovation, and consistently forges ahead on the road to promoting human health development.
founded in 2008.
certificated by CFDA for conduct of GLP studies.
accredited by AAALAC.
conducted non-clinical studies supporting for CFDA/FDA submission.
TriApex(Nanjing) Clinical Medicine was founded
TriApexPharmaceutical Research Launches OECD Qualification Certification/SEND System Online
Shanghai TriApex Biotechnology Co., Ltd. was founded
TriApex passed the re-inspection by NMPA.
TriApex (Shanghai) in operation
TriApex Med Chengdu Beauty Medical (dedicated to ophthalmology) was founded.
TriApex achieved group management
acquisition of Kunming KBI.
a laboratory animal resource platform was founded/ layout of disease-oriented R&D (Ophthalmology/CNS/Metabolic Disease) was deepened /international business development was strengthened.